Scientists at Aston University have found a way to significantly increase the antimicrobial properties of a material used in many medical devices and clinical surfaces: bioactive glass. The Aston University team had already developed bacteria-killing bioactive glass laced with a single metal oxide of either zinc, cobalt or copper. Their latest research combined pairs of metal oxides in the material - and found that some combinations were more than 100 times better at killing bacteria than using single oxides alone.
Agilent Technologies has announced that the recipient of the 2022 Darlene Solomon Award is Federica Fiorini, Ph.D., a research associate studying metabolomics at the Institute of Biology and Pathology at the Grenoble Alpes University Hospital (CHU Grenoble Alpes) in France. The award was presented at the iSLS10–10th International Singapore Lipid Symposium held March 8–10 at the National University of Singapore....
The first Pharma User Club meeting organized by Granutools was successfully held on January 26th, 2022. More than 200 attendees joined this virtual meeting, which was the perfect occasion to hear renowned speakers, join a large and diverse community, and network. The talks covered a wide range of subjects and aspects of the pharmaceutical industry and academy: from lactose excipients to APIs, from flowability to electrostatics, from feedstock to production lines, from process simulation to model calibration...
Medix Biochemica, a global leader in critical IVD raw materials, has acquired 100 percent of the shares of myPOLS Biotec GmbH (“myPOLS Biotec”). As a result of the acquisition, Medix Biochemica broadens its portfolio of molecular diagnostic raw materials for the in vitro diagnostics (“IVD”) industry, complements its scientific expertise and strengthens its local presence in Western Europe...
Olympus, a leading global manufacturer of optical and digital precision technology, announced a partnership with evorion biotechnologies, a pioneer in advanced single-cell analysis using unique microfluidic systems. By merging evorion’s cutting-edge 3D hydrogel bead technology and Olympus’ leading microscope systems, the collaboration introduces a seamless and largely automated workflow solution to capture functional phenotypes of individual cells´ behavior over time...
Ziath has chosen Analytica 2022 in Munich, Germany (21-24th June) to launch two new innovative sample management products - Handheld 3 and LUX. Designed for easy portability, the new Ziath Handheld 3 is a compact and powerful device for reading single 2D bar-coded tubes and editing or updating the sample information, adding extra details, or changing locations in a connected LIMS or database software directly from wherever you keep your samples....
Eppendorf has made a strategic investment in BigOmics Analytics SA, a software company from Switzerland that develops digital cloud-based self-service tools to analyze molecular biology research data. “We’re excited to invest in BigOmics,” said Peter Fruhstorfer, Co-CEO of Eppendorf SE, upon signing the agreement. “With its expertise and digital know-how, the company is a perfect fit for Eppendorf and our ambition to improve work processes in the lab and set them up for the future...
INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipettes save time and improve lab productivity, and the company has created a testimonial video showcasing the pipette’s many useful features. The video shows how the VOYAGER increases productivity using a real-life situation, portraying how researchers at the National Centre for Scientific Research (CNRS) in Montpellier, France, are using it to study the dynamics of the latent HIV reservoir and investigate drug-resistant mutations...
AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical industry, has announced a $14.2 million investment to open a new manufacturing facility located in Manheim Borough, Lancaster County, Pennsylvania. The new state-of-the-art facility will see 97 full-time jobs created and will serve as a manufacturing hub for its modular cleanroom systems....
New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound design. Optibrium Ltd, a leading developer of software for drug discovery, has announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, optimisation and data analysis. More than 160 organisations currently use StarDrop, including many of the world’s leading pharmaceutical companies....
Simplified calculation model for tissue properties developed at Karl Landsteiner University for Health Sciences Krems (Austria). Viscous mechanical properties of biological tissues can now be described more easily than before. This is shown by a recently published paper of a team of the Karl Landsteiner University of Health Sciences Krems. The team demonstrates that an established mathematical model for soft biological tissues can be greatly simplified, allowing extensive time and cost savings...
EVONETIX LTD the synthetic biology company bringing semiconductor technology to DNA synthesis, has announced it has achieved enzymatic DNA synthesis capability with its proprietary, thermally controlled synthesis chemistry. The culmination of a three-year development program, supported by Innovate UK and in collaboration with Durham University, the results demonstrate that Evonetix’s unique, semiconductor array-based platform is compatible with both chemical and enzymatic DNA synthesis...
BioChromato has published a technical note that compares using Evolved Gas Analysis (EGA) and Thermal Desorption (DART) sample preparation methods for Mass Spectrometry analysis of Nylon 6,6. Synthesized by polycondensation of hexamethylenediamine and adipic acid – Nylon 6,6 is a polyamide or nylon that is commonly used in the textile and plastic industries. Nylon 6,6 is a polymer of choice when high mechanical strength, rigidity, good stability under heat and/or chemical resistance are required....
With the addition of Overwatch’s end-to-end animal study management and execution system, Benchling’s R&D Cloud platform will be able to tackle the challenge of preclinical reproducibility, and help biopharma companies and contract research organisations (CROs) reduce errors, increase confidence for first-in-human studies, and ultimately get drugs to patients faster...
“Automation and industrialization of COVID-19 PCR-testing will facilitate an immense scale-up of the global PCR-testing capacity. It will allow for a new approach to keep society open: preventive, regular testing (twice per week), which will create green bubbles and get us ahead of the curve” - Niels Kruize, CCO, MolGen. To get ahead of the curve, we will need to change our methodology of COVID-19 testing...
Microbiome DX company Genetic Analysis AS (“GA”) and Institut für Medizinische Diagnostik (“IMD”), a part of the Medicover Group, announces that IMD has launched the GA-map® Dysbiosis Test in Germany. IMD will activate its new Microbiome laboratory in February 2022 and add standardized microbiota testing to its existing test portfolio of products. This new Microbiota test offering will be marketed to customers in Germany and Europe...
A 'waste collection' tidies up our cells. If something does not go according to plan, serious diseases such as Alzheimer’s or Parkinson's may develop. Molecular biologist Sascha Martens from the University of Vienna together with international partners – researchers of the University of Pennsylvania, Monash University, the Max Planck Institute of Biophysics in Frankfurt and the UC Berkeley – investigate the associated process: autophagy...
NHS guidelines for gene testing miss half of people carrying inherited genetic changes linked to cancer, a new study reports. Scientists assessed patients who received testing in the private sector to see who would have been eligible for a genetic test under the NHS – and what the consequences would have been of missing testing. The team at The Institute of Cancer Research, London, found that applying NHS guidelines for gene testing would have excluded many people...
Tired of the slow and tedious process of identifying non-target compounds and/or setting up semi-quantitative analysis for those compounds? Imagine a system that provides superior identification by combining Library Search, Retention Index (RI), and Accurate Mass to confidently ID unknowns. Imagine a system that does so automatically, without the need for tedious standards and visually highlights correct identifications among a long list of possible matches...
Biotage helps shape the sustainable science of tomorrow and our future society for the benefit of humankind – HumanKind Unlimited. With this principle Biotage has set out a commitment to unleashing the potential of humanity by working tirelessly to improve the health and wellbeing of both our customers through greener and more efficient solutions, and our own employees through smarter working practices....
OxDX, a University of Oxford spin out building instant pathogen tests using super-resolution microscopy and machine learning,has raised £2.6m in pre-seed funding for its AI powered diagnostic technology that can recognise and identify specific species and strains of viruses1,2, bacteria and other pathogens within a sample in seconds. The initial funding is co-led by IQ Capital and Ahren Innovation Capital with participation from Science Creates Ventures, and will be used to expand the team and further validate the technology with development partners...
Agilent Technologies Inc. announce that researchers from the QIMR Berghofer Medical Research Institute in Brisbane, Australia, collaborated with Agilent experts on a proof-of-concept FTIR-based saliva COVID-19 testing workflow using the Agilent Cary 630 FTIR Spectrometer. The study investigated the pathophysiological response to a COVID-19 infection through ATR-FTIR spectroscopy....